What amount sold does OurPharma Holdings LLC report in Form D filings?

The latest linked filings report $16.2M sold across 3 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was OurPharma Holdings LLC's most recent SEC filing?

OurPharma Holdings LLC's most recent Form D filing was on 2026-07-10.

How many investors does OurPharma Holdings LLC have?

The most recent Form D filing lists 3 investor(s).

What type of securities does OurPharma Holdings LLC offer?

OurPharma Holdings LLC's SEC Form D filings indicate equity offerings.

OurPharma Holdings LLC

CIK: 0001725565·Pharmaceuticals·FAYETTEVILLE, AR·Limited Liability Company

Reported Sold

$16,175,000

Total Filings

Identified Offerings

Last Filed

Jul 10, 2026

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Other Health Care industry

SEC EDGAR

Offering filing timeline

Jul 10, 2026Form D/A — Amendment

Reported sold: $500,000 · Target: $3,450,000

Rule 506(b)·3 investors

Changed: Reported amount sold, Reported investors

Jul 23, 2025Form D — New notice

Reported sold: $250,000 · Target: $3,450,000

Rule 506(b)·1 investor

Feb 20, 2024Form D/A — Amendment

Reported sold: $13,450,000 · Target: $17,000,000

Rule 506(b)·30 investors

Changed: Reported amount sold, Reported investors

Feb 24, 2023Form D/A — Amendment

Reported sold: $10,450,000 · Target: $17,000,000

Rule 506(b)·19 investors

Changed: Reported amount sold, Offering target, Reported investors

Mar 10, 2022Form D/A — Amendment

Reported sold: $9,950,000 · Target: $12,000,000

Rule 506(b)·24 investors

Changed: Reported amount sold, Offering target, Reported investors

Oct 7, 2021Form D/A — Amendment

Reported sold: $5,500,000 · Target: $9,000,000

Rule 506(b)·13 investors

Changed: Reported amount sold, Offering target, Reported investors

Dec 10, 2020Form D/A — Amendment

Reported sold: $3,500,000 · Target: $6,000,000

Rule 506(b)·10 investors

Changed: Reported amount sold, Offering target, Reported investors

Aug 14, 2019Form D — New notice

Reported sold: $1,900,000 · Target: $3,000,000

Rule 506(b)·6 investors

Dec 21, 2017Form D — New notice

Reported sold: $2,225,000 · Target: $3,500,000

Rule 506(b)·7 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

67%

Latest reported sold across 3 identified offerings

$16,175,000

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Todd Kohler

Related Person

Appears on 8 filings

Peter Kohler

Related Person

Appears on 8 filings

Adam Kohler

Related Person

Appears on 8 filings

Michael Mauldin

Related Person

Appears on 7 filings

Brooke Erwin

Related Person

Appears on 7 filings

Stephen Kohler

Related Person

Appears on 7 filings

Ramona McLean

Related Person

Appears on 3 filings

Brent Beaulieu

Related Person

Appears on 2 filings

Filing History

Date	Type	Offering target	Reported sold	Investors
Jul 10, 2026	Amendment	$3,450,000	$500,000	3
Jul 23, 2025	New	$3,450,000	$250,000	1
Feb 20, 2024	Amendment	$17,000,000	$13,450,000	30
Feb 24, 2023	Amendment	$17,000,000	$10,450,000	19
Mar 10, 2022	Amendment	$12,000,000	$9,950,000	24
Oct 7, 2021	Amendment	$9,000,000	$5,500,000	13
Dec 10, 2020	Amendment	$6,000,000	$3,500,000	10
Aug 14, 2019	New	$3,000,000	$1,900,000	6
Dec 21, 2017	New	$3,500,000	$2,225,000	7

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

LUCIER PHARMACEUTICALS INC

Pharmaceuticals

Offering target: $2,000,000

Filed Oct 13, 2026